Retaglutide is a novel GLP-1 receptor agonist currently under study for the control of obesity. This drug works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone that controls https://aliviaudzn148596.prublogger.com/37927708/trelaglutide-exploring-a-new-option-for-chronic-diseases